| 000 | 01360 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517151045.0 | ||
| 264 | 0 | _c20171113 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a1747-0285 | ||
| 024 | 7 |
_a10.1111/cbdd.13004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPavlova, Anna | |
| 245 | 0 | 0 |
_aToward the rational design of macrolide antibiotics to combat resistance. _h[electronic resource] |
| 260 |
_bChemical biology & drug design _cNov 2017 |
||
| 300 |
_a641-652 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xchemistry |
| 650 | 0 | 4 |
_aAzithromycin _xanalogs & derivatives |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 |
_aErythromycin _xchemistry |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 |
_aEscherichia coli Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKetolides _xchemistry |
| 650 | 0 | 4 |
_aMacrolides _xchemistry |
| 650 | 0 | 4 | _aMolecular Dynamics Simulation |
| 650 | 0 | 4 |
_aPoint Mutation _xdrug effects |
| 650 | 0 | 4 |
_aRibosomes _xdrug effects |
| 700 | 1 | _aParks, Jerry M | |
| 700 | 1 | _aOyelere, Adegboyega K | |
| 700 | 1 | _aGumbart, James C | |
| 773 | 0 |
_tChemical biology & drug design _gvol. 90 _gno. 5 _gp. 641-652 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cbdd.13004 _zAvailable from publisher's website |
| 999 |
_c27090909 _d27090909 |
||